Equity Analysis

Quarterly Results

    Concord Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543960
    INE338H01029
    145.7950166
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    CONCORDBIO
    60.29
    18959.07
    EPS(TTM)
    Face Value()
    Div & Yield %:
    30.06
    1
    0.48
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales215.80318.97240.80
Other Operating Income0.000.000.00
Other Income 10.3110.818.19
Total Income226.11329.78248.98
Total Expenditure 134.52184.68134.87
PBIDT91.59145.10114.12
Interest 0.240.460.50
PBDT91.35144.64113.62
Depreciation13.1813.7213.54
Tax19.3929.9825.80
Fringe Benefit Tax0.000.000.00
Deferred Tax0.533.73-0.27
Reported Profit After Tax58.2497.2174.55
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item58.2497.2174.55
EPS (Unit Curr.)5.579.297.13
EPS (Adj) (Unit Curr.)5.579.297.13
Calculated EPS (Unit Curr.)5.579.297.13
Calculated EPS (Adj) (Unit Curr.)5.579.297.13
Calculated EPS (Ann.) (Unit Curr.)22.2737.1728.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)22.2737.1728.51
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4610.4610.46
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)42.4445.4947.39
PBDTM(%)42.3345.3547.18
PATM(%)26.9930.4830.96
Dividend Per Share(Rs)0.000.000.00
Diluted EPS5.579.297.13